ACD/PhysChem Selected to Teach Medicinal Chemistry at the Royal Society of Chemistry School
Toronto, Canada, June 4, 2003-
Advanced Chemistry Development, Inc., (ACD/Labs) and The Royal Society of Chemistry today announced the incorporation of ACD/PhysChem, which offers tools for the prediction of PhysChem properties, into RSC's Medicinal Chemistry School.
For the third year in a row, ACD/LogD Sol Suite, a module of ACD/PhysChem, will be used to assist in the teaching of medicinal chemists. LogD Sol Suite provides a full array of tools for the prediction of PhysChem properties of compounds such as pKa, pH-dependent logD, logP, and aqueous solubility. "We are naturally very pleased to be part of this important educational forum for tomorrow's leaders in Medicinal Chemistry," comments Robert DeWitte, Ph.D., Director of Medicinal Chemistry Solutions at ACD/Labs.
Designed for medicinal chemists, ACD/LogD Sol Suite will be incorporated into tutorials and presentations to display the importance of physicochemical properties in pharmaceutical research at RSC's Medicinal Chemistry School. "Through guided hands-on use of ACD/Labs software, we find that people are able to gain an insight into the relationship between the chemical structure of molecules and their associated physicochemical properties," said Rupert Austin, Ph.D., AstraZeneca.
Increasingly, throughout the industry, drug discovery projects are actively aiming to design pharmaceutical properties into their lead candidates, to enhance their likelihood of clinical success. Insofar as the pharmacokinetics is driven by passive physiological processes, this goal can be achieved by modulating the molecule's physical properties. Given access to accurate predictions of these properties at design time, compounds can be selectively prioritized for synthesis so as to optimize ADME.
About Advanced Chemistry Development
Advanced Chemistry Development, Inc., (ACD/Labs) is a chemistry software company offering solutions that truly integrate chemical structures with analytical chemistry information to produce ChemAnalytics™. ACD/Labs creates innovative software packages that aid chemical research scientists worldwide with spectroscopic validation of structures, elucidation of unknown substances, chromatographic separation, medicinal chemistry, preformulation of novel drug agents, systematic nomenclature generation, and chemical patenting and publication. Combined, ACD/Labs' solutions create an analytical informatics system that provides dramatic feed-forward effects on the chemical and pharmaceutical research process. Founded in 1993, and headquartered in Toronto, Canada, ACD/Labs employs a team of over 100 dedicated individuals whose continual efforts carry ACD/Labs' innovative technologies into pharmaceutical, biotech, chemical, and materials companies throughout the world. Information about Advanced Chemistry Development and its products can be found at www.acdlabs.com.
About the Royal Society of Chemistry's Medicinal Chemistry School
Specialized for graduate and post-doctoral chemists in the field of drug research, students attending the RSC Medicinal Chemistry School will gain an appreciation of the fundamentals of medicinal chemistry and allied subjects such as physical chemistry, quantitative structure activity relationship (QSAR), drug metabolism, pharmacokinetics and molecular biology. Throughout this course a series of lectures and hands-on demonstrations, the factors governing the relationship between chemical structure and physical properties will be studied along with how these relationships can be used in drug design. Additional information can be found at http://www.chemsoc.org/CFCONF/alldetails.cfm?ID=10710.
|
